NPI: 1609842889 · WASHINGTON, DC 20019 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,456 | $490K |
| 2019 | 30,975 | $388K |
| 2020 | 27,116 | $242K |
| 2021 | 26,530 | $150K |
| 2022 | 28,216 | $347K |
| 2023 | 14,473 | $394K |
| 2024 | 4,362 | $265K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 55,161 | 3,920 | $2.00M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 47,935 | 2,420 | $209K |
| J1756 | Injection, iron sucrose, 1 mg | 9,761 | 2,036 | $28K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,192 | 400 | $19K |
| J1270 | Injection, doxercalciferol, 1 mcg | 28,754 | 2,395 | $7K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 433 | 211 | $6K |
| A4657 | Syringe, with or without needle, each | 6,354 | 2,874 | $839.96 |
| 83970 | 3,149 | 2,250 | $818.46 | |
| 90674 | 159 | 119 | $623.96 | |
| 82728 | 1,866 | 1,487 | $152.64 | |
| 82108 | 582 | 460 | $126.78 | |
| 83550 | 2,234 | 1,671 | $115.82 | |
| 83540 | 2,483 | 1,813 | $92.34 | |
| 85041 | 2,894 | 2,080 | $56.31 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 366 | 201 | $52.32 |
| 85048 | 2,889 | 2,079 | $47.24 | |
| 0012A | 26 | 14 | $47.10 | |
| G0008 | Administration of influenza virus vaccine | 182 | 116 | $37.49 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 687 | 77 | $0.00 |
| 90662 | 21 | 13 | $0.00 |